FDA: Insulin Among Drugs Transitioned to Biological Products

TUESDAY, March 24, 2020 -- Insulin and other biologic drugs, such as human growth hormone, have now transitioned to being regulated as biological products, providing a new pathway for approval of biosimilars and interchangeable versions of these...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news